Reading Time: 2 minutesIntroduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a pivotal therapeutic agent in the management of type 2 diabetes. Its role in enhancing glycemic control, particularly in the postprandial phase, is of significant interest to healthcare providers …